Prospective study of antibiotic prophylaxis for prostate biopsy involving > 1100 men

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Manecksha, Rustom P ^a   Nason, Gregory J ^a   Cullen, Ivor M ^a   Fennell, Jérme P ^a   McEvoy, Elizabeth ^a   McDermott, Ted ^a   Flynn, Robert J ^a   Grainger, Ronald ^a   Thornhill, John A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; EXTENDED SPECTRUM BETA LACTAMASE; MEROPENEM; OFLOXACIN; QUINOLONE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; QUINOLONE DERIVATIVE; THIENAMYCIN DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; ENTEROCOCCUS; ESCHERICHIA COLI; FEVER; HUMAN; HUMAN TISSUE; INFECTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE BIOPSY; SEPSIS; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; URINALYSIS; AGED; ANTIBIOTIC PROPHYLAXIS; BIOPSY; METHODOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FEVER; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; QUINOLONES; SEPSIS; THIENAMYCINS; TREATMENT OUTCOME;

EID: 84862329705     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/650858     Document Type: Article

References (25)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P., Estimates of the cancer incidence and mortality in Europe in 2006 Annals of Oncology 2007 18 3 581 592 (Pubitemid 46359643)
2. Collin S. M., Martin R. M., Metcalfe C., Gunnell D., Albertsen P. C., Neal D., Hamdy F., Stephens P., Lane J. A., Moore R., Donovan J., Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study The Lancet Oncology 2008 9 5 445 452
3. Lange D., Zappavigna C., Hamidizadeh R., Goldenberg S. L., Paterson R. F., Chew B. H., Bacterial Sepsis After Prostate Biopsy-A New Perspective Urology 2009 74 6 1200 1205
4. Matsumoto T., Kiyota H., Matsukawa M., Yasuda M., Arakawa S., Monden K., Japanese guidelines for prevention of perioperative infections in urological field International Journal of Urology 2007 14 10 890 909 (Pubitemid 47432549)
5. Wolf J. S. Jr, Bennett C. J., Dmochowski R. R., Hollenbeck B. K., Pearle M. S., Schaeffer A. J., Best practice policy statement on urologic surgery antimicrobial prophylaxis Journal of Urology 2008 179 4 1379 1390
6. Grabe M., Bishop M. C., Bjerklund-Johansen T. E.,. Guidelines on the management of urinary and male genital infections, 2009, http://www.uroweb.org/ professional-resources/guidelines/online/?nocache=1view=archive
7. Bootsma A. M. J., Laguna Pes M. P., Geerlings S. E., Goossens A., Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review European Urology 2008 54 6 1270 1286
8. Burden H. P., Ranasinghe W., Persad R., Antibiotics for transrectal ultrasonography-guided prostate biopsy: Are we practising evidence-based medicine? British Journal of Urology International 2008 101 10 1202 1204 (Pubitemid 351549638)
9. Aron M., Rajeev T. P., Gupta N. P., Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study British Journal of Urology International 2000 85 6 682 685 (Pubitemid 30192834)
10. Kamdar C., Mooppan U. M. M., Gulmi F. A., Kim H., Multi-Drug-Resistant Bacteremia After Transrectal Ultrasound Guided Prostate Biopsies in Hospital Employees and Their Relatives Urology 2008 72 1 34 36
11. Cam K., Kayikci A., Akman Y., Erol A., Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy International Journal of Urology 2008 15 11 997 1001
12. Briffaux R., Coloby P., Bruyere F., Ouaki F., Pires C., Doré B., Irani J., One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy British Journal of Urology International 2009 103 8 1069 1073
13. Bean D. C., Krahe D., Wareham D. W., Antimicrobial resistance in community and nosocomial Escerichia coli urinary tract isolates, London 2005-2006 Annals of Clinical Microbiology and Antimicrobials 2008 7 13 16
14. Berger A. P., Gozzi C., Steiner H., Frauscher F., Varkarakis J., Rogatsch H., Bartsch G., Horninger W., Complication rate of transrectal ultrasound guided prostate biopsy: A comparison among 3 protocols with 6, 10 and 15 cores Journal of Urology 2004 171 4 1478 1480 (Pubitemid 38365399)
15. Young J. L., Liss M. A., Szabo R. J., Sepsis due to fluoroquinolone- resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy Urology 2009 74 2 332 338
16. Feliciano J., Teper E., Ferrandino M., Macchia R. J., Blank W., Grunberger I., Colon I., The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? Journal of Urology 2008 179 3 952 955
17. Taylor H. M., Bingham J. B., Antibiotic prophylaxis for transrectal prostate biopsy Journal of Antimicrobial Chemotherapy 1997 39 2 115 117 (Pubitemid 27116403)
18. Shandera K. C., Thibault G. P., Deshon G. E., Variability in patient preparation for prostate biopsy among American urologists Urology 1998 52 4 644 646 (Pubitemid 28440173)
19. Chen F.-J., Lo H. J., Molecular mechanisms of fluoroquinolone resistance Journal of Microbiology, Immunology and Infection 2003 36 1 1 9 (Pubitemid 36402408)
20. Boyd L. B., Atmar R. L., Randall G. L., Hamill R. J., Steffen D., Zechiedrich L., Increased fluoroquinolone resistance with time in Escherichia coli from 17,000 patients at a large county hospital as a function of culture site, age, sex, and location BMC Infectious Diseases 2008 8 4
21. Chappell B., O'Brien T., Infections after prostate biopsy and antibiotic resistance British Journal of Urology International 2009 103 3 409
22. Yuk K. H., Nightingale C. H., Quintiliani R., Sweeney K. R., Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers Antimicrobial Agents and Chemotherapy 1991 35 2 384 386
23. Dromigny J. A., Nabeth P., Juergens-Behr A., Perrier-Gros-Claude J. D., Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal Journal of Antimicrobial Chemotherapy 2005 56 1 236 239 (Pubitemid 41418365)
24. Ozden E., Bostanci Y., Yakupoglu K. Y., Akdeniz E., Yilmaz A. F., Tulek N., Sarikaya S., Incidence of acute prostatitis caused by extended-spectrum -lactamase-producing Escherichia coli after transrectal prostate biopsy Urology 2009 74 1 119 123
25. Batura D., Rao G. G., Nielsen P. B., Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy British Journal of Urology International 2010 106 7 1017 1020